Antiretroviral tolerability and efficacy after switch to saquinavir in PI-experienced patients : 48-week analysis of the German Rainbow Cohort

Poster presentation: Purpose of the study The aim of the Rainbow Cohort is to assess the tolerability and efficacy of initiating treatment with, or switching treatment to the saquinavir (SQV) 500 mg film-coated tablet formulation. We present the final 48-week subgroup analysis of PI-experienced, but SQV-naïve patients. ...

Metadaten
Author:	Christoph Stephan ORCiD GND, Hans Jäger, Andreas Carganico, Gaby Knecht, Thomas Lutz, Christoph Mayr, Franz Mosthaf, Siegfried Koeppe, Markus Mueller, Eva Wolf, Andre Tappe, Egbert Wellmann, Heribert Knechten
URN:	urn:nbn:de:hebis:30-70723
DOI:	https://doi.org/10.1186/1758-2652-11-S1-P25
Parent Title (English):	Journal of the International AIDS Society
Publisher:	Springer
Place of publication:	Berlin ; Heidelberg
Document Type:	Article
Language:	English
Date of Publication (online):	2009/09/20
Date of first Publication:	2008/11/10
Publishing Institution:	Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:	Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
Release Date:	2009/09/20
Volume:	11(Suppl 1)
Issue:	P25
Page Number:	2
First Page:	1
Last Page:	2
Note:	© 2008 Stephan et al; licensee BioMed Central Ltd.
Source:	Journal of the International AIDS Society 2008, 11(Suppl 1):P25 ; doi:10.1186/1758-2652-11-S1-P25 ; from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
HeBIS-PPN:	21888463X
Institutes:	Medizin / Medizin
Dewey Decimal Classification:	6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):	Deutsches Urheberrecht

Open Access